BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23990346)

  • 1. Overexpression of PTP1B in human colorectal cancer and its association with tumor progression and prognosis.
    Chen Q; Li Y; Li Z; Zhao Q; Fan L
    J Mol Histol; 2014 Apr; 45(2):153-9. PubMed ID: 23990346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
    Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
    Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome.
    Hoekstra E; Das AM; Swets M; Cao W; van der Woude CJ; Bruno MJ; Peppelenbosch MP; Kuppen PJ; Ten Hagen TL; Fuhler GM
    Oncotarget; 2016 Apr; 7(16):21922-38. PubMed ID: 26942883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTP1B expression contributes to gastric cancer progression.
    Wang J; Liu B; Chen X; Su L; Wu P; Wu J; Zhu Z
    Med Oncol; 2012 Jun; 29(2):948-56. PubMed ID: 21442314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer.
    Li R; Liu B; Yin H; Sun W; Yin J; Su Q
    J Mol Histol; 2013 Apr; 44(2):183-9. PubMed ID: 23108908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulated expression of the protein-tyrosine phosphatase 1B (PTP1B) is associated with aggressive clinicopathologic features and poor prognosis in hepatocellular carcinoma.
    Zheng LY; Zhou DX; Lu J; Zhang WJ; Zou DJ
    Biochem Biophys Res Commun; 2012 Apr; 420(3):680-4. PubMed ID: 22450318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
    Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
    Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT.
    Liu X; Chen Q; Hu XG; Zhang XC; Fu TW; Liu Q; Liang Y; Zhao XL; Zhang X; Ping YF; Bian XW
    Tumour Biol; 2016 Oct; 37(10):13479-13487. PubMed ID: 27465552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical significance of absent in melanoma 2 in colorectal cancer.
    Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S
    Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ).
    Cordeiro HG; de Sousa Faria AV; Ferreira-Halder CV
    Biol Chem; 2020 Aug; 401(9):1063-1069. PubMed ID: 32229687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
    Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
    Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.
    Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB
    BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
    Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
    Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated CNTN1 is associated with lymph node metastasis and poor prognosis of colorectal cancer.
    Li G; Zhang Z; Ge G; Fang K; Zhu J
    Cancer Biomark; 2021; 30(2):193-201. PubMed ID: 33104020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.